Topic

Humana

A collection of 1312 issues

How to Get Keytruda (Pembrolizumab) Covered by Humana in New Jersey: Prior Authorization, Appeals, and Cost-Saving Strategies

Answer Box: Getting Keytruda Covered by Humana in New Jersey Keytruda (pembrolizumab) requires prior authorization from Humana in New Jersey. Your oncologist must submit clinical documentation showing FDA-approved indication, prior therapy failures, and medical necessity. If denied, you have 65 days to appeal internally, then 180 days for New Jersey&
6 min read

How to Get Revlimid (Lenalidomide) Covered by Humana in Pennsylvania: Appeals Guide, Forms, and Coding Requirements

Answer Box: Revlimid Coverage with Humana in Pennsylvania Revlimid (lenalidomide) requires prior authorization from Humana in Pennsylvania. The fastest path to approval involves three key steps: (1) Ensure REMS certification for both prescriber and pharmacy, (2) Submit Humana's prior authorization form with complete clinical documentation including ICD-10 codes
5 min read

Myths vs. Facts: Getting Garadacimab (Anti-FXIIa) Covered by Humana in New Jersey - Complete Prior Authorization Guide

Answer Box: Getting Garadacimab Covered by Humana in New Jersey Garadacimab (Andembry) requires prior authorization from Humana in New Jersey for all plans, including Medicare Advantage. The fastest path to approval: (1) Confirm HAE diagnosis with C1-INH testing, (2) Document failed/contraindicated alternatives, (3) Complete REMS training documentation. If denied,
5 min read

Renewing Evkeeza (Evinacumab) Approval with Humana in Illinois: Complete Timeline and Documentation Guide

Answer Box: Renewing Evkeeza with Humana in Illinois Evkeeza (evinacumab) renewals with Humana Medicare Advantage require annual prior authorization with updated clinical documentation. Submit renewal requests 30-60 days before current authorization expires. Required documents include: current LDL-C levels, treatment response data, continued HoFH diagnosis confirmation, and evidence of ongoing medical
6 min read